WHO, ITU, and WIPO release new report on AI use in traditional medicine
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
The company’s largest center for medical device applications, serving the entire Asian market
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Subscribe To Our Newsletter & Stay Updated